[Proliferative activity and defective replication in breast cancer]
- PMID: 7534009
[Proliferative activity and defective replication in breast cancer]
Abstract
The highly proliferating phenotype of mammary carcinoma is known to be associated with a particularly aggressive clinical course. We have been interested in the underlying molecular causes that give rise to the increased proliferative activity Proliferative activity was determined immunohistochemically by the detection of topoisomerase II-alpha (Ki-S1). The subgroup of highly proliferating tumors with a Ki-S1 index exceeding 30% was characterized by a high frequency of c-myc amplification and aberrant p53 expression, whereas tumors, with a low mitotic activity rarely exhibited gene amplification or an altered p53 expression. We conclude, that the highly proliferating phenotype is not capable of regular replication and tends to develop gene amplifications. One of the causes might be a defective cell cycle control by p53.
Similar articles
-
Amplification of c-myc but not of c-erbB-2 is associated with high proliferative capacity in breast cancer.Cancer Res. 1993 Apr 15;53(8):1956-61. Cancer Res. 1993. PMID: 8096798
-
Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.J Pathol. 1999 Jan;187(2):207-16. doi: 10.1002/(SICI)1096-9896(199901)187:2<207::AID-PATH223>3.0.CO;2-U. J Pathol. 1999. PMID: 10365096
-
Amplification of the TOP2A gene does not predict high levels of topoisomerase II alpha protein in human breast tumor samples.Genes Chromosomes Cancer. 2004 Apr;39(4):288-97. doi: 10.1002/gcc.20008. Genes Chromosomes Cancer. 2004. PMID: 14978790
-
Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancer.Hum Pathol. 2001 Mar;32(3):311-9. doi: 10.1053/hupa.2001.22748. Hum Pathol. 2001. PMID: 11274641
-
Clinical relevance of breast cancer biology.Hematol Oncol Clin North Am. 1994 Feb;8(1):1-14. Hematol Oncol Clin North Am. 1994. PMID: 7512087 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous